A startup that runs one of the world’s largest health-care digital platforms is seeking to leverage artificial intelligence ...
China International Capital Corp. is rebuilding its pipeline of initial public offerings and conducting thorough due ...
Fast-forward to 2026, and we’ve already seen a handful of U.S. biotechs line up to squeeze through a gradually reopening IPO ...
The valuation increased threefold since its last valuation in 2023.
Ethos was backed by a who's who of VCs and celebs through 2021. It is currently profitable, it says.
The debut signals a shift for digital asset infrastructure, with Goldman Sachs and Citigroup leading the underwriting ...
By Echo Wang and Prakhar Srivastava Jan 22 (Reuters) - Elon Musk's space startup SpaceX is lining up four Wall Street banks ...
SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...
Elon Musk’s SpaceX has reportedly tapped four major banks to lead what is expected to be one of the largest initial public ...
The four Wall Street firms are currently selling existing shares valuing the company at $800 billion, according to reports.
VanEck analyst calls it a "superior asset" within its valuation range.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results